Discontinued — last reported Q3 '17
Biogen Senior unsecured notes, net increased by 0.0% to $6.29B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 0.1%, from $6.30B to $6.29B. Over 5 years (FY 2020 to FY 2025), Senior unsecured notes, net shows a downward trend with a -3.3% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase suggests higher leverage and interest costs, while a decrease indicates debt repayment or deleveraging.
This represents the principal amount of debt obligations issued by the company that are not backed by specific collatera...
Typically compared against other investment-grade insurers or financial institutions to assess relative cost of capital.
reit_unsecured_notes| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $7.27B | $7.27B | $7.27B | $7.28B | $7.28B | $6.28B | $6.28B | $6.28B | $6.28B | $6.29B | $6.94B | $6.54B | $6.29B | $6.29B | $6.30B | $6.30B | $6.28B | $6.29B | $6.29B | $6.29B |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +0.0% | -13.7% | +0.0% | +0.0% | +0.0% | +0.0% | +10.4% | -5.7% | -3.8% | +0.0% | +0.0% | +0.0% | -0.2% | +0.0% | +0.0% | +0.0% |
| YoY Change | — | — | — | — | +0.1% | -13.6% | -13.6% | -13.6% | -13.6% | +0.1% | +10.5% | +4.1% | +0.1% | +0.1% | -9.3% | -3.7% | -0.1% | -0.1% | -0.1% | -0.1% |